M31.1
Thrombotic microangiopathy
Clinical Classification Guidelines
Medical Intelligence & Overview
Thrombotic microangiopathy (TMA) is a rare but serious condition involving the formation of tiny blood clots in small blood vessels throughout the body. These clots can block the flow of blood and oxygen to vital organs, leading to significant health problems. TMA encompasses a group of disorders characterized by microvascular thrombosis, hemolytic anemia, and thrombocytopenia. The condition can occur as a primary disorder or as a result of other diseases or factors. Recognizing and understanding TMA is crucial for timely diagnosis and management to prevent complications.
Causes & Symptoms
Clinical Causes: Genetic mutations affecting blood clot regulation Autoimmune diseases such as systemic lupus erythematosus Certain infections, including bacterial or viral illnesses Medications, notably chemotherapy agents and certain antibiotics Pregnancy-related conditions like preeclampsia or HELLP syndrome Cancer or cancer treatments Other underlying health conditions that damage blood vessels
Key Symptoms: Fatigue and weakness Paleness or jaundice due to hemolytic anemia Blood in urine or decreased urine output Unusual bruising or bleeding Fever Confusion or neurological symptoms such as headaches and seizures Shortness of breath Swelling in legs or other areas
Diagnostic & Treatment
Diagnosis Path: Complete blood count (CBC) to evaluate anemia and platelet levels Blood smear examination to detect hemolysis Lactate dehydrogenase (LDH) levels to assess cell destruction Haptoglobin levels Coagulation studies to rule out other clotting disorders Kidney function tests Complement levels for specific subtypes Biopsy of affected tissue, if necessary
Treatment Protocols: Plasma exchange therapy to remove harmful substances and supply beneficial factors Medications such as corticosteroids to suppress immune activity Immunosuppressive drugs in cases linked to autoimmune processes Supportive care including blood transfusions and dialysis for kidney involvement Treating the underlying cause—such as infections or medications Monitoring and managing organ function throughout treatment
Clinical Advice & FAQs
Billing Guidance
Is M31.1 a billable ICD-10 code?
Yes, M31.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report M31.1?
Clinical documentation must specify the nature of Thrombotic microangiopathy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference